There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains.
- Join NJ ACTS for a Special Lecture on 12/19, 12-1:30
- NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.
- Researchers Suggest Stress Hormones Explain How Obesity Causes Diabetes.
- Rutgers Study Reveals Vaccination Patterns Among LGBTQ+ Adults in New Jersey and New York.
Categories
- Community (2,077)
- Covid (979)
- CTO Events (5)
- News (2,638)
- Pilots (20)